• No results found

A nationwide overview of 1-year mortality in cardiac arrest patients admitted to intensive care units in the Netherlands between 2010 and 2016

N/A
N/A
Protected

Academic year: 2021

Share "A nationwide overview of 1-year mortality in cardiac arrest patients admitted to intensive care units in the Netherlands between 2010 and 2016"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Clinical

paper

A

nationwide

overview

of

1-year

mortality

in

cardiac

arrest

patients

admitted

to

intensive

care

units

in

the

Netherlands

between

2010

and

2016

Loes

Mandigers

a,

*

,

Fabian

Termorshuizen

b,c

,

Nicolette

F.

de

Keizer

b,c

,

Diederik

Gommers

a

,

Dinis

dos

Reis

Miranda

a

,

Wim

J.R.

Rietdijk

a,1

,

Corstiaan

A.

den

Uil

a,d,1

a

DepartmentofIntensiveCare,ErasmusMCUniversityMedicalCenter,Rotterdam,TheNetherlands

b

NationalIntensiveCareEvaluation(NICE)Foundation,Amsterdam,TheNetherlands

cDepartmentofMedicalInformatics,AmsterdamUMC,AmsterdamPublicHealthResearchInstitute,UniversityofAmsterdam,Amsterdam,The

Netherlands

dDepartmentofCardiology,ErasmusMCUniversityMedicalCenter,Rotterdam,TheNetherlands

Abstract

Aim:Worldwide,cardiacarrest(CA)remainsamajorcauseofdeath.Mostpost-CApatientsareadmittedtotheintensivecareunit(ICU).Theaimofthis studyistodescribemortalityratesandpossiblechangesinmortalityratesinpatientswithCAadmittedtotheICUintheNetherlandsbetween2010and 2016.

Methods:Inthisstudy,weincludedalladultCApatientsregisteredintheNationalIntensiveCareEvaluation(NICE)registrywhowereadmittedtoICUs intheNetherlandsbetween2010and2016.Theprimaryoutcomewas1-yearmortalitywhichwasanalysedbyCoxregression.Thesecondary outcomeswereICUmortalityandhospitalmortality.Hospitalmortalitywasanalysedbybinarylogisticregressionanalysis.Patientswerestratifiedby whethertheyexperiencedin-hospitalcardiacarrest(IHCA)orout-of-hospitalcardiacarrest(OHCA).Finally,theoutcomeovercalendartimewas assessedforbothgroups.

Results:Weincluded26,056CApatients:10,618(40.8%)IHCApatientsand14,482(55.6%)OHCApatients.The1-yearmortalityratewas57.5%: 59%forIHCAand56.4%forOHCA,p<0.01.Thismortalityrateremainedstablebetween2010and2016forIHCA(p=0.31)anddeclinedforOHCA patients(p=0.01).Thehospitalmortalityratewas50.3%:50.5%forIHCAand50.2%forOHCA,p=0.66.Thismortalityrateremainedstablebetween 2010 2016forIHCA(p=0.21)anddecreasedforOHCApatients(p<0.01).Anadditionalanalysiswithcalendaryearasacontinuousvariableshowed amortalitydeclineof1.56%percalendaryearfor1-yearmortality.

Conclusion:Thisnationwideregistrycohortstudyreporteda57.5%1-yearmortalityrateforCApatientsadmittedtotheICUbetween2010and2016. Wereportedadeclinein1-yearmortalityforOHCApatientsintheseyears.

Keywords:Cardiacarrest,Heartarrest,Intensivecareunits,ICU,Mortality,1-yearmortality

* Correspondingauthorat:ErasmusMCUniversityMedicalCenter,DepartmentofAdultIntensiveCare,DoctorMolewaterplein40,Rotterdam,3015GD, TheNetherlands.

E-mailaddress:l.mandigers@erasmusmc.nl(L.Mandigers).

1

Sharedlastauthor.

https://doi.org/10.1016/j.resuscitation.2019.12.029

;Accepted27December2019

0300-9572/©2020TheAuthor(s).PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/ licenses/by-nc-nd/4.0/).ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Available

online

at

www.sciencedirect.com

Resuscitation

(2)

Introduction

Suddencardiacarrest(CA)remainsamajorcauseofdeathworldwide (World Health Organization, WHO). In Europe, approximately 375,000adultssufferannuallyfromCA.1,2Mortalityratesinpatients admittedtothehospitalduetoCAhavebeenreportedtobebetween 58 61%.3 5IftheseCApatientsareadmittedtotheintensivecare

unit(ICU),mortalityratesvarybetween53 66%.6 8Ofallsurviving

CApatients25 75%havepoorneurologicaloutcomesandalarge portionsuffersfromlong-termsideeffects,9 11suchaspost-traumatic stress disorder (PTSD),12,13 impaired quality of life,14 and lower physicalandmentalfunctioning.15

Recentstudieshaveexaminedcharacteristicsthatareassociated withthemortality ofCApatients. Morespecifically, these studies focusedondifferencesinpatientcharacteristics,16,17thelocationof theCA(in-orout-of-hospital),18 20andhospitalcharacteristics.4,6 Generally,thesestudiesprovidedataonallCApatients,including patientswhodiedbeforehospitaladmission.However,thereisno recentstudyshowinganationwideoverviewofCApatientsadmitted totheICU.

IntheNetherlands,4.6%ofallpatientsadmittedtotheICUhave CAasprimarydiagnosis.21Theoutcomesofthesepatientsarehighly

interestingbecausetheysurvivedthefirstepisodeofCA(namely, cardiopulmonaryresuscitation).However,theyareproneto haemo-dynamicdeterioration/instability, ischaemia/reperfusion injury, and neurologicaldamage.Inaddition,large-scaledataontheoutcomesin thispatientgrouparelacking.Thisinformationwouldbeparticularly relevantgivenrecentchangesinguidelinesandtreatments,suchas targetedtemperaturemanagement(TTM).22Therefore,weanalysed

alargenationaldatabaseto investigatethemortalityratesin CA patients(bothIHCAandOHCA)admittedtoICUsintheNetherlands.

Methods

Patientdata

Inthisstudy,weusedpatientdataincludedintheNationalIntensive CareEvaluation(NICE)registry.21Thisisanationalqualityregistryin

theNetherlandsforICUcare,inwhichdemographics,physiological anddiagnosticdata,patientoutcomes,andICUcharacteristicsare registered.Thedataareprospectivelycollectedwithaprimaryfocus on monitoring the qualityof care in theICU. We retrospectively analysedthedatafromapproximately85%ofICUdepartmentsin 2010to100%ofICUdepartmentsin2016intheNetherlands.21,23

WeincludedalladultCApatients(18years)whowereadmittedto theparticipatingICUsfrom 2010to2016.Thisperiodwasselected becausestartingin2010,wewereabletodetermine1-yearmortality.21,23 TheScientificBoardoftheNICEFoundation(number2018-01)andthe Medical Ethics Committee of the Erasmus MC, Rotterdam, the Netherlands(numberMEC-2018-1228)approvedthisstudyandthe needforinformedconsentwaswaived.

Characteristicsandclinicaloutcomes

Weincludedpatientcharacteristics(i.e.,sex,age,bodymassindex (BMI),andhistory(e.g.,renalinsufficiency/dialysis,chronicobstructive pulmonarydisease(COPD)/chronicrespiratoryinsufficiency, cardio-vascularinsufficiency,livercirrhosis,(haematologic)malignancy,and immunologic insufficiency)), admission characteristics (i.e., Acute

Physiology and Chronic Health Evaluation (APACHE IV) score, estimatedmortalityrateanddiagnoseswithin24hofICUadmission (e.g., acutekidney injury(AKI), the useof mechanicalventilation, infection, the administration of thrombolytic therapy, vasoactive medicationuse,andacademic/non-academichospital),andclinical outcomes(lengthofstay,ICUmortality,hospitalmortality,and1-year mortality).SupplementaryMaterialTableAshowsthedefinitionsof thesevariables.

First, we included all patients (henceforth referred to as CA patients)registeredwithanadmissiondiagnosisofCAor cardiopul-monaryresuscitation(CPR).Next,westratifiedthecharacteristics andclinicaloutcomesforIHCAandOHCApatients.However,IHCA andOHCAwerenotencodedin theNICEregistry.Therefore,we definedIHCAasanadmissiondiagnosisofCAorCPR,withadmission originwithinthehospital,excludingtheemergencydepartment(ED). OHCAwasdefinedasanadmissiondiagnosisofCAorCPR,withan admissionoriginintheEDorhome.Hospitaland1-yearmortalityrates werecalculated,andhazardratios(HRs)peryearwereassessed relativetotheyear2010.Wedeterminedthe1-yearmortalitybyusing anadministrativeclaimsdatabasethatislinkedtotheNICEregistry (i.e.,Vektisdata).23,24

Statisticalanalysis

Allcharacteristicsandclinicaloutcomesweredescribedascounts(%) andmedians(interquartilerange,IQR),asappropriate.Thedataare shownforthetotalsampleandwerestratifiedbyIHCAandOHCA. Patients with unknown locations of CA were excluded from the stratifiedanalyses.TotestfordifferencesbetweenIHCAandOHCA patients,weusedChi-squareandWilcoxontestsforcategoricaland continuousvariables,respectively.

Theprimary outcomewas 1-year mortality. Weexaminedthe mortalitytrendovertimeusingaCoxproportionalhazardmodelwith calendaryearsfrom2010to2016asanindependentvariable.For eachcalendaryear,adummyvariablewasincluded.Thevariableswe included in each of the regression models are stated in the Supplementary Material Appendix 1. We built these regression modelsintwoways:(1)univariableanalysis and(2)multivariable analysisadjustingfordemographicandclinicalcharacteristicsand includingarandominterceptforhospital.Thiswasdonetotakethe correlationbetweenpatientsfromthesamehospitalintoaccount.To checkwhethertheselectionofdifferenthospitalsacrossthecalendar yearsmighthaveinfluencedtheresults,weperformedasensitivity analysisrestrictedtohospitalsthatregisteredtheirpatientsineach calendar year of the studyperiod (2010 2016). We presentthe hazardratios(HR)and95%ConfidenceIntervals(95%CI)ofmodel (2),asthiswasthebestpossiblerepresentationofalltheavailable data.Theadjustedeffectofcalendaryearasacategoricalvariableon thehazardofdeathwastestedbymeansofapost-estimationWald test with numberof degrees of freedomequal to the numberof calendaryearsminus1(forthereferencecategory=2010).Inthistest, calendaryearwasincludedascategoricalvariablewithoutassuming a linear trend. As an additional analysis, we performed Cox proportional hazards regression, including calendar year as a continuous variable for the different outcomes. These analyses enabledustoestimatetheaveragechangeinmortalityratesperyear overtime.AllmodelswereanalysedforIHCAandOHCAseparately. IHCAandOHCAwerenotcomparedintheseanalysesbecauseofthe non-registeredcharacteristicsrelevanttoCA.

(3)

Our secondary outcomes were ICU mortality and hospital mortality.ForICUmortality,weonlypresentapercentagetomake aroughcomparisonwithhospitalmortality.Forhospitalmortality,we analysed the data using a binary logistic regression model and presentedtheOddRatios(ORs)and95%CIs.All analyseswere performedusingR-studio.Ap-value<0.05wasconsidered statisti-callysignificant.

Results

Between2010and2016,atotalof567,856patientswereincludedin the NICE registry, and 26,056 (4.6%) of those patients were admitted due to CA: 10,618 (40.8%) IHCA patientsand 14,482 (55.6%) OHCA patients. Data from 956 (3.6%) patients were excluded fromthecomparisonof OHCAversusIHCAdue toan unknownlocationoftheCA.

Descriptivestatistics

Table1presentsthepatientcharacteristicsofallCApatientsandthen thoseofthepatientsstratifiedintotheIHCAandOHCAgroups.The majorityoftheCApatientsweremale,withanaverageageof67years atthetimeofthearrest.IHCApatientswereolderandhadoverallmore comorbiditiesthanOHCApatients.Table2presentstheadmission characteristics.ThemedianAPACHEIVestimatedmortality proba-bilitywas0.75.ThemajorityofpatientshadaGlasgowcomascale (GCS) at admission of 5 (61.7%). At admission, 87.1% of the patientsweremechanicallyventilated.Table3presentstheclinical outcomes.ThemedianlengthofICUstaywas64h(IQR21-134)and themedianhospitallengthofstaywas6days(IQR2-15).

Primaryoutcome:1-yearmortality

WithinoneyearafterICUadmission,14,974(57.5%)CApatients died.This1-yearmortalitywassignificantlyhigherinIHCApatients (59.0%)versusOHCApatients(56.4%,p<0.01).InSupplementary Material Fig. A, we present the Kaplan Meier curve for 1-year mortalityforIHCAandOHCApatients.Fig.1presentstheanalysis ofmodel(2),asdescribedinthemethodssection,of1-yearmortality for IHCA and OHCA patients separately. In IHCA patients no significantdifferencesovertimewereobserved.InOHCApatientsa

significantdecreasein1-yearmortalitybetween2010and2016was observed (all p<0.02). The sensitivity analyses restricting to hospitalsthatrecruited patientsthefullstudyperiodgavesimilar results.

Secondaryoutcomes:ICUmortality,hospitalmortality,and additionalanalyses

Ofthetotalsample,11,681(44.8%)CApatientsdiedintheICU.The ICU mortality rates were slightly lowerfor IHCA than for OHCA patients(44.2%versus45.4%,respectively,p=0.05).Duringtheir hospitaladmission,13,072(50.3%)CApatientsdied.Thishospital mortalityratewascomparableinIHCAandOHCApatients(50.5% versus50.2%,respectively,p=0.66).

For hospital mortality, there was no significant trend in IHCA patientsovertime(Waldtest(df)8.39(6),p=0.21).However, the analysisforhospitalmortalityinOHCApatientswithcalendaryearasa categorised variable showed significant differences between the calendaryearsWaldtest(df)22.78(6),p<0.01).InspectingtheOdds Ratioswefoundadecreasingtrend,asshowninFig.2.

Next,theresultsoftheadditionalanalysiswithcalendaryearasa continuousvariableshowednosignificanttrendin1-yearmortality overtimeforIHCApatients(HR0.99,95%CI0.98-1.00,p=0.13). Furthermore,itconfirmed theobserveddeclinein1-yearmortality overtimeforOHCApatients(HR0.98,95%CI0.97-1.00,p<0.01). ThisHRshowsareductionin1-yearmortalityof1.56%peryearover thestudyperiod.

As wefoundadecreasing trendin 1-yearmortalityfor OHCA patients,wedecidedtoperformanadditionalCoxregressionusingleft truncationatthetimeofhospitaldischarge(i.e.,onlyselectingthe hospitalsurvivors),seeSupplementaryMaterialFig.B.Thisshows thatasignificanttrendovertimeremainspresent(p<0.01).

Discussion

Thisisthefirstlargenationwidestudyon1-yearmortalityratesofCA patientsadmittedtotheICU,anditwasperformedintheNetherlands between2010and2016.Thesecondaryoutcomeswedescribedwere ICUmortalityandhospitalmortality.Overall,wefoundreasonable mortalityratesandasignificantdecreasein1-yearmortalityofOHCA patientsbetween2010and2016.

Table1–Patientcharacteristics.

Totalsamplea IHCA OHCA p-value

Patients2010 2016 26,056 10,618 14,482 Age(IQR) 67(57 76) 69(59 77) 66(55 75) <0.01 Gender,male(%) 17,320(66.5) 6731(63.4) 9967(68.8) <0.01 BMI(IQR) 25.7(23.4 28.7) 25.7(23.4 28.9) 25.7(23.4 28.4) 0.99 BMImissing(%) 711(6.6) 985(6.8) History(N=26,056) Cardiovascularinsufficiency(%) 2291(8.8) 1160(10.9) 1030(7.1) <0.01

COPD/respiratoryinsufficiency(%) 4070(15.6) 1894(17.8) 2042(14.1) <0.01

Renalinsufficiency(%) 1802(6.9) 976(9.2) 765(5.3) <0.01

Livercirrhosis(%) 273(1) 138(1.3) 125(0.9) 0.01

(Hematologic)malignancy(%) 1092(4.2) 692(6.5) 374(2.6) <0.01

Immunodeficiency(%) 1316(5.1) 779(7.3) 500(3.5) <0.01

(4)

Table2AdmissioncharacteristicsinCApatientsadmittedtotheICUbetween2010 2016.

Totalsamplea IHCA OHCA p-value

APACHEIVestimatedmortalityrate(IQR) 0.75(0.45 0.89) 0.71(0.32 0.90) 0.77(0.54 0.88) <0.01

Admissiontype <0.01 Medical 23,156(88.9) 7968(75) 14,291(98.7) Urgentsurgical 1682(6.5) 1517(14.3) 122(0.8) Electivesurgical 1103(4.2) 1088(10.2) 6(<1) Diagnosisonadmission GCS5(%) 16,066(61.7) 5333(50.2) 10,167(70.2) <0.01 GCS6 14(%) 4057(15.6) 1736(16.3) 2148(14.8) GCS15(%) 5391(20.7) 3327(31.3) 1851(12.8) GCSmissing(%) 222(2.1) 316(2.2) Dysrhythmia(%) 13,343(51.2) 5138(48.4) 7676(53) <0.01 Mechanicalventilation(%) 22,701(87.1) 8696(81.9) 13,189(91.1) <0.01 CVA(%) 1053(4.1) 455(4.3) 558(3.9) 0.10 Intracranialmass(%) 708(2.7) 264(2.5) 421(2.9) 0.04

Gastrointestinalbleeding(%) 480(1.8) 277(2.6) 189(1.3) <0.01

Diabetes(%) 4438(17) 2045(19.3) 2221(15.3) <0.01

Diagnosisat24hofICUadmission

GCS5(%) 13,541(52) 4615(43.5) 8420(58.1) <0.01 GCS6 14(%) 4198(16.1) 1621(15.3) 2407(16.6) GCS15(%) 7664(29.4) 4095(38.6) 3312(22.9) AKI(%) 4617(17.7) 2263(21.3) 2188(15.1) <0.01 Mechanicalventilation(%) 23,666(90.8) 9229(86.9) 13,592(93.9) <0.01 Infection(%) 2768(10.6) 1641(15.5) 1062(7.3) <0.01 Vasoactivemedication(%) 18,962(72.8) 7640(72) 10,652(73.6) <0.01 Thrombolytictherapy(%) 1354(5.2) 560(5.3) 756(5.2) 0.87 Academichospital(%) 7956(23.9) 3102(22.2) 4656(26.1) <0.01

aIn956patients,itwasunknownifthecardiacarrestoccurredin-oroutsidethehospital;thesepatientswereexcludedfromtheanalyses.

Table3ClinicaloutcomesinCApatientsadmittedtotheICUbetween2010 2016.

Totalsamplea IHCA OHCA p-value

LengthofICUstayinhours(IQR) 64.2(21.4 133.8) 52.1(17.2 135.2) 69(26.4 133.2) <0.01

Hospitallengthofstayindays(IQR) 5.9(1.8 14.8) 6.1(1.5 15.1) 5.9(2 14.6) 0.27

ICUmortality(%) 11,681(44.8) 4690(44.2) 6579(45.4) <0.05

Hospitalmortality(%) 13,072(50.3) 5346(50.5) 7256(50.2) 0.66

1-yearmortality(%) 14,974(57.5) 6263(59.0) 8169(56.4) <0.01

aIn956patients,itwasunknownifthecardiacarrestoccurredinoroutsidethehospital;thesepatientswereexcludedfromtheanalyses.

Fig.1–MultivariableCoxregressionanalysisof1-yearmortalityforIHCA(p=0.31)andOHCA(p=0.01)overcalendar time.

(5)

Asaprimaryoutcome,wereporteda1-yearmortalityrateof57.5% inthetotalcohort.This1-yearmortalityratewasslightlyhigherinIHCA patientsthaninOHCApatients.Thoughinasmallersample,Engsig etal.25investigatedlong-term outcomesandshowedcomparable

1-yearmortalityrates,whichweresimilarforIHCAandOHCApatients (47%and51%,respectively).Wefoundastable1-yearmortalityrate between2010and2016forIHCApatients.Remarkably,the1-year mortalityofOHCApatientsdecreasedinthistimeperiod,andthis decreasepersistedafterlimitingtheanalysistothehospitalsurvivors (seeSupplementaryMaterialFig.C).Thiscouldpointtoahealthier dischargedCApatientpopulation.

Asasecondaryoutcome,westudiedhospitalmortality,whichwas approximately50%inthetotalcohort,aswellasforbothIHCAand OHCApatientsseparately.Inaddition,wefoundthathospitalmortality wasstableforIHCApatientsbetween2010and2016.ForOHCA,we foundadecreasingtrendinhospitalmortalityinthistimeperiod.These mortalityratesarein linewiththose inpreviousstudiesreporting hospitalmortalityratesinCApatients.7,26 28

Inthisstudy,wefoundamedianAPACHEIVestimatedmortality rateof0.75,whichismuchhigherthantheobservedhospitalmortality rate.Zimmermanet al.29 validated thisAPACHE IVscore forCA patientsintheUnitedStates.However,Brinkmanetal.30showedpoor APACHEIVscoreperformanceinCApatientsintheNetherlands.Our studywasperformedwiththesamedataregistryaswasthestudyby Brinkmanetal.30BecausetheAPACHEIVscoreisnotvalidatedforCA

patientsintheNetherlands,thisdifferenceinexpectedandobserved mortalitycouldbeexplained.

Giventhelimitationsofanationwideobservationaldataset,we couldnotfullystudytheunderlyingcauseforthereductioninmortality among the OHCA patients. However, we would like to discuss possibleexplanationsforthedifferencesinmortalityratesbetween IHCAandOHCApatients andthedecline in1-year andhospital mortalityofOHCApatients.

First,althoughwehavecorrectedouranalysesforrelevantpatient characteristics, CAcharacteristics may have changed during the studyperiod.Forexample,intheNetherlandspublicawarenessofCA isincreasingovertimeduetonationwideeducation.31Thiscouldhave resulted in a higher percentage of bystander life support and automated externaldefibrillator(AED)use.In turnthismayhave

resultedinashortertimetothereturnofspontaneouscirculation (ROSC),whichwewereunabletoexamineinthepresentstudy.

Second,AEDusemayhavecontributedtothe decreaseinthe mortality rate in OHCA patients. Despite the promising results, worldwide AED use is still quite limited compared to the Netherlands.18,20,32,33Blometal.32showedthatintheNetherlands, theuseofAEDsandhospitalsurvivalbothincreasedovertimeinthe period2006 2012.Inthissameperiod,Ringhetal.34reportedan

increase inthenumberanduseofpublic AEDsanditseffectonmortality ratesinSweden.Takentogether,inouropinion,thewidespreaduseof AEDsintheNetherlandsprobablycontributedtothedecreasein1-year mortalityinOHCApatientsfoundinourstudy.

Anotherpossibleexplanationforthedecreaseinthemortalityrate in OHCApatientsisthepredominantuseoftargetedtemperature management(TTM),comparedtoitslimiteduseinIHCApatients. Mountingresearchhasbeenperformedontemperaturemanagement in CA patients,8,22,27,28,35 37 mostly these studies have been performedinOHCApatients.Asstatedinthe2015guidelines,since 2010,atemperatureof32 34Cisrecommended,whichchangedin 2015 to36C.22 Severalstudies showeddifferent results ingoal

temperaturesfortheTTM,buttheyallrecommendusinghypothermia or normothermiaand preventinghyperthermia.8,22,35 37 However, Engsigetal.25showednodifferenceinIHCAandOHCApatients.

Wangetal.38showedabenefitforTTMinIHCApatients,butTTMwas

performedinonly3.2%ofthepatients.Chanetal.39alsoshowedalow

TTMrateinIHCApatientsandtheyfoundnoassociationbetween TTMandsurvivalorneurologicaloutcomes.IntheNetherlands,itis difficulttopinpointtheexactdateoftheimplementationoftheTTM guidelines,asshownbyPickkersetal,8whileatthesametimemany

hospitals started usingTTM forOHCA patientsduring our study period.Thus,thismayhavecontributedtothedifferencesinmortality trendsbetween2010and2016inIHCAandOHCApatientsfoundin ourstudy.Takentogether,TTMisusedmoreofteninOHCApatients andhasshownsomepromisingresults.However,TTMisnotusedas ofteninIHCApatients,althoughthismayactuallybe apromising treatmentstrategyforthesepatientstoo.

Fourth,intheNetherlands,nostudieshavebeenconductedon theeffectofcardiacrehabilitationonthemortalityratespecificallyin CA patients. However, some studies on the effect of cardiac Fig.2–BinarylogisticregressionanalysisofhospitalmortalityforIHCA(p=0.21)andOHCA(p<0.01)overcalendar time.

(6)

rehabilitationon mortality in acute coronary syndrome and cardiac surgerypatientsshowedalowermortalityrateforthosewhoreceived cardiacrehabilitationcomparedtothosewhodidnot.40,41OHCApatients

aremorelikelytoreceivecardiacrehabilitation.10,42Forthesepatients,a cardiac cause such as coronary disease, was most likely the reason for the CA.Giventhedecreasein1-year mortalityratesinourstudy,which persisted after selecting only hospital survivors, it is likely that rehabilitation therapycontributedtothislower1-yearmortalityinOHCApatients.Itmay clarifythedifferencebetweenIHCAandOHCAoutcomes.

Finally,duringthelastdecadethetreatmentofcoronarydiseases improved.Advancesincoronaryrevascularizationandadherenceto secondarypreventionguidelines(includinginternalcardiacdefibrillatory therapy)mayhavecontributedtoanimportantimprovementinmortality ratesinOHCApatients,whilethisisnotthecaseinIHCApatients.

Future research may study the possible effects of pre-ICU characteristicsandin- andpost-hospitaltreatmentson short-and long-termmortalityratesofCApatientsadmittedtotheICU.Ourlinear trendshould beregardedasacrudeaverageofvariousup- and downwardmovementsofthegraph.Intherestrictedtimeframeofour analysis,thesemovementsarehardtointerpretascoincidenceordue tospecificcauses.Forthisreason,nononlineartrendswereincluded intheanalysis.Incaseastudycanbeperformedwithmoredata relevanttoCAfromalongertimeperiodamorespecifictrendanalysis (e.g.non-lineartrend)willbeinformative.

Limitations

Asinevery(retrospective)study,thisresearchhadseverallimitations. First,asmentionedbefore,theNICEregistryisaimedatqualityofcare attheICUandnotallcharacteristicsrelevanttoCAareregistered.In particular,wedidnot haveaccesstothe followingcharacteristics: witnessed/unwitnessed CA,CPR delay, time until ROSC,primary cardiacrhythm,cardiacinterventions,AEDuse,mechanical compres-sion deviceuseand cause of arrest. Thesecharacteristicsare important whenstudyingthedeterminantsoftheoutcomeofCA.Therefore,in futureresearch,thesecharacteristicsmustbetakenintoaccount.

Second,theNICEregistrydoesnotrecordwhethertheCAtook placein-orout-of-hospital.Wehadtodeterminethiswiththebest possibleapproximation.Withthismethod,weexpectthatsomeofthe IHCApatientswere misclassifiedasOHCA. Mostofthe patients admittedattheICUwithadmission-originEDwereOHCApatients; however,someofthemexperiencedCAwhileintheED.Weassume thatthisissuehaslimitedconsequencesfortheresults,butwecannot excludethepossibilityofsomebias.

Third, in this study, we could only report mortality rates. Unfortunately,therewerenodataavailableonneurologicaloutcomes; therefore,wewereunabletoreportsurvivalwithgoodneurological outcome.

Finally,insomehospitalsintheNetherlands,post-CApatientsare admittedtothecardiaccareunitinsteadoftheICU.Wewereunableto estimatehowmanypatientswereinthisgroupasthisisnotrecorded orthesedatawerenotavailabletotheauthors.Asaconsequence,this couldresultindifferentnumbersofpatientsincomparisontotheCA numbersreportedinotherstudies.

Conclusion

This nationwide registry cohort study reported a 57.5% 1-year mortalityrateforCApatientsadmittedtotheICUbetween2010and

2016.Wereportedadeclinein1-yearmortalityforOHCApatientsin theseyears.

Conflicts

of

interest

None.

Acknowledgments

None.

Appendix

A.

Supplementary

data

Supplementarymaterialrelatedtothisarticlecanbefound,inthe onlineversion,atdoi:10.1016/j.resuscitation.2019.12.029.

REFERENCES

1.AtwoodC,EisenbergMS,HerlitzJ,ReaTD.Incidenceof EMS-treatedout-of-hospitalcardiacarrestinEurope.Resuscitation 2005;67:75 80.

2.NolanJP,SoarJ,SmithGB,etal.Incidenceandoutcomeofin-hospital cardiacarrestintheUnitedKingdomNationalCardiacArrestAudit. Resuscitation2014;85:987 92.

3.GutermanEL,KimAS,JosephsonSA.Neurologicconsultationand useoftherapeutichypothermiaforcardiacarrest.Resuscitation 2017;118:43 8.

4.KurzMC,DonnellyJP,WangHE.Variationsinsurvivalaftercardiac arrestamongacademicmedicalcenter-affiliatedhospitals.PLoSOne 2017;12:e0178793.

5.RushB,AshkananiM,RomanoK,HertzP.Utilizationof electroencephalogrampostcardiacarrestintheUnitedStates:a nationwideretrospectivecohortanalysis.Resuscitation

2017;110:141 5.

6.SchoberA,HolzerM,HochrieserH,PoschM,SchmutzR,MetnitzP. Effectofintensivecareaftercardiacarrestonpatientoutcome:a databaseanalysis.CritCare2014;18:R84.

7.StraneyLD,BrayJE,FinnJ,BernardS,PilcherD.Trendsinintensive careunitcardiacarrestadmissionsandmortalityinAustraliaandNew Zealand.CritCareResusc2014;16:104 11.

8.vanderWalG,BrinkmanS,BisschopsLL,etal.Influenceofmild therapeutichypothermiaaftercardiacarrestonhospitalmortality.Crit CareMed2011;39:84 8.

9.PeruckiWH,HiendlmayrB,O’SullivanDM,GunaseelanAC,FayasF, FernandezAB.Magnesiumlevelsandneurologicoutcomesin patientsundergoingtherapeutichypothermiaaftercardiacarrest.Ther HypothermiaTempManag2018;8:14 7.

10.RadeschiG,MinaA,BertaG,etal.Incidenceandoutcomeof in-hospitalcardiacarrestinItaly:amulticentreobservationalstudyinthe PiedmontRegion.Resuscitation2017;119:48 55.

11.WangCH,HuangCH,ChangWT,etal.Outcomesofadultswith in-hospitalcardiacarrestafterimplementationofthe2010resuscitation guidelines.IntJCardiol2017;249:214 9.

12.GamperG,WilleitM,SterzF,etal.Lifeafterdeath:posttraumatic stressdisorderinsurvivorsofcardiacarrest—prevalence,associated factors,andtheinfluenceofsedationandanalgesia.CritCareMed 2004;32:378 83.

13.MongardonN,DumasF,RicomeS,etal.Postcardiacarrest syndrome:fromimmediateresuscitationtolong-termoutcome.Ann IntensiveCare2011;1:45.

(7)

14.WachelderEM,MoulaertVR,vanHeugtenC.Lifeaftersurvival: long-termdailyfunctioningandqualityoflifeafteranout-of-hospitalcardiac arrest.Resuscitation2009;80:517 22.

15.BunchTJ,WhiteRD,GershBJ,etal.Long-termoutcomesof out-of-hospitalcardiacarrestaftersuccessfulearlydefibrillation.NEnglJ Med2003;348:2626 33.

16.Al-DuryN,RawshaniA,IsraelssonJ,etal.Characteristicsand outcomeamong14,933adultcasesofin-hospitalcardiacarrest:a nationwidestudywiththeemphasisongenderandage.AmJEmerg Med2017;35:1839 44.

17.LibunganB,LindqvistJ,StromsoeA,etal.Out-of-hospitalcardiac arrestintheelderly:alarge-scalepopulation-basedstudy. Resuscitation2015;94:28 32.

18.HawkesC,BoothS,JiC,etal.Epidemiologyandoutcomesfrom out-of-hospitalcardiacarrestsinEngland.Resuscitation2017;110:133 40.

19.KazaureHS,RomanSA,SosaJA.Epidemiologyandoutcomesof in-hospitalcardiopulmonaryresuscitationintheUnitedStates,2000

2009.Resuscitation2013;84:1255 60.

20.RoYS,ShinSD,SongKJ,etal.Atrendinepidemiologyandoutcomes ofout-of-hospitalcardiacarrestbyurbanizationlevel:anationwide observationalstudyfrom2006to2010inSouthKorea.Resuscitation 2013;84:547 57.

21.NICE.Datainbeeld.2016.

22.NolanJP,SoarJ,CariouA,etal.EuropeanResuscitationCounciland EuropeanSocietyofIntensiveCareMedicine2015guidelinesfor post-resuscitationcare.IntensiveCareMed2015;41:2039 56.

23.vandeKlundertN,HolmanR,DongelmansDA,deKeizerNF.Data resourceprofile:theDutchNationalIntensiveCareEvaluation(NICE) RegistryofAdmissionstoAdultIntensiveCareUnits.IntJEpidemiol 2015;44:1850-h.

24.KarakusA,HaasLEM,BrinkmanS,deLangeDW,deKeizerNF. Trendsinshort-termand1-yearmortalityinveryelderlyintensivecare patientsintheNetherlands:aretrospectivestudyfrom2008to2014. IntensiveCareMed2017;43:1476 84.

25.EngsigM,SoholmH,FolkeF,etal.Similarlong-termsurvivalof consecutivein-hospitalandout-of-hospitalcardiacarrestpatients treatedwithtargetedtemperaturemanagement.ClinEpidemiol 2016;8:761 8.

26.CarrBG,GoyalM,BandRA,etal.Anationalanalysisofthe relationshipbetweenhospitalfactorsandpost-cardiacarrestmortality. IntensiveCareMed2009;35:505 11.

27.JonesD,BhasaleA,BaileyM,PilcherD,AnsteyMH.Effectofa nationalstandardfordeterioratingpatientsonintensivecare admissionsduetocardiacarrestinAustralia.CritCareMed 2018;46:586 93.

28.SalterR,BaileyM,BellomoR,etal.Changesintemperature managementof cardiac arrestpatients followingpublicationofthetarget temperaturemanagementtrial.CritCareMed2018;46:1722 30.

29.ZimmermanJE,KramerAA,McNairDS,MalilaFM,ShafferVL. Intensivecareunitlengthofstay:benchmarkingbasedonAcute

PhysiologyandChronicHealthEvaluation(APACHE)IV.CritCare Med2006;34:2517 29.

30.BrinkmanS,Bakhshi-RaiezF,Abu-HannaA,etal.Externalvalidation ofAcutePhysiologyandChronicHealthEvaluationIVinDutch intensivecareunitsandcomparisonwithAcutePhysiologyand ChronicHealthEvaluationIIandSimplifiedAcutePhysiologyScoreII. JCritCare201126:105e11-8.

31.Hartstichting.Forsetoenamesnellehulpbijeenhartstilstand. Hartstichting;2019.

32.BlomMT,BeesemsSG,HommaPC,etal.Improvedsurvivalafter out-of-hospitalcardiacarrestanduseofautomatedexternaldefibrillators. Circulation2014;130:1868 75.

33.GirotraS,vanDiepenS,NallamothuBK,etal.Regionalvariationin out-of-hospitalcardiacarrestsurvivalintheUnitedStates.Circulation 2016;133:2159 68.

34.RinghM,JonssonM,NordbergP,etal.Survivalafterpublicaccess defibrillationinStockholm,Sweden—astrikingsuccess.

Resuscitation2015;91:1 7.

35.DonninoMW,AndersenLW,BergKM,etal.Temperature managementaftercardiacarrest:anadvisorystatementbythe advancedlifesupporttaskforceoftheInternationalLiaisonCommittee onResuscitationandtheAmericanHeartAssociationEmergency CardiovascularCareCommitteeandtheCouncilonCardiopulmonary, CriticalCare,PerioperativeandResuscitation.Resuscitation 2016;98:97 104.

36.KalraR,AroraG,PatelN,etal.Targetedtemperaturemanagement aftercardiacarrest:systematicreviewandmeta-analyses.Anesth Analg2018;126:867 75.

37.SchenoneAL,CohenA,PatarroyoG,etal.Therapeutichypothermia aftercardiacarrest:Asystematicreview/meta-analysisexploringthe impactofexpandedcriteriaandtargetedtemperature.Resuscitation 2016;108:102 10.

38.WangCH,HuangCH,ChangWT,etal.Outcomesofadultin-hospital cardiacarresttreatedwithtargetedtemperaturemanagement:a retrospectivecohortstudy.PLoSOne2016;11:e0166148.

39.ChanPS,BergRA,TangY,CurtisLH,SpertusJA.AmericanHeart Association’sGetWiththeGuidelines-ResuscitationI.Association BetweenTherapeuticHypothermiaandSurvivalAfterIn-Hospital CardiacArrest.JAMA2016;316:1375 82.

40.SunamuraM,TerHoeveN,vandenBerg-EmonsRJG,BoersmaE, vanDomburgRT,GeleijnseML.Cardiacrehabilitationinpatientswith acutecoronarysyndromewithprimarypercutaneouscoronary interventionisassociatedwithimproved10-yearsurvival.EurHeartJ QualCareClinOutcomes2018;4:168 72.

41.deVriesH,KempsHM,vanEngen-VerheulMM,KraaijenhagenRA, PeekN.Cardiacrehabilitationandsurvivalinalargerepresentative communitycohortofDutchpatients.EurHeartJ2015;36:1519 28.

42.DumasF,ReaTD.Long-termprognosisfollowingresuscitationfrom out-of-hospitalcardiacarrest:roleofaetiologyandpresentingarrest rhythm.Resuscitation2012;83:1001 5.

Referenties

GERELATEERDE DOCUMENTEN

Our aim was to construct models and estimate necessary parameters for yearling body weight (BW), clean fleece weight (CFW) and mean fibre diameter (MFD) of South African Dohne

De gegevens worden elk twee minuten naar de computer overgezonden waar op basis van de locatie van de verschillende sensoren een grafische representatie van het klimaat wordt

De drie noordelijke provincies hebben naar verhouding iets meer provinciale wegen dan heel Nederland en geen waterschapswegen.. Met ruim 17 miljoen inwoners en bijna 140 duizend

Essai de datation par les pollens et les Fora- minifères d'un forage Effectué au Bosq d'Aubigny

(c) In gevalle waar die hoof nie die superinten- dent is nie, moet laasgenoemde aIle opgawes, ver s lae en briefwisseling oor koshuissake deur bemiddeling van sy

Uit de technische resultaten in tabel 4 blijkt, dat er geen aantoonbare verschillen zijn in groei en dagelijkse voeropname tussen de proefbehandelingen.. De groei van de

In dit hoofdstuk onderzoek ik in welke mate de lichtbehoefte, dan wel tolerantie voor schaduw van kiemplanten van zomer- en wintereik, zomer- en winterlinde, beuk, haagbeuk

Bij deze verwachting is de volgende onderzoeksvraag opgesteld: In welke mate is er een relatie tussen de psychologische afstand van een aanslag en de manier waarop daar in